期刊文献+

早期非小细胞肺癌患者hsa-mir-34b基因启动子甲基化水平检测 被引量:5

The promoter methylation of hsa-mir-34b gene in early stage non-small cell lung cancer
下载PDF
导出
摘要 目的 检测早期非小细胞肺癌(NSCLC)患者癌组织与癌旁组织hsa-mir-34b(mir-34b)基因启动子甲基化水平的差异.方法 采用重亚硫酸盐还原技术、降落巢式PCR扩增27例Ⅰ期NSCLC患者癌组织和癌旁组织配对样本中mir-34b基因启动子区DNA,克隆测序法分析甲基化谱变异,并与临床病理特征进行关联分析.结果 癌组织mir-34b基因启动子CpG岛整体甲基化水平为9.7%(6.8%~22.3%),而癌旁组织为8.5%(5.3%~11.0%),癌组织甲基化水平高于癌旁组织(Z=2.355, P=0.019).当前吸烟患者mir-34b基因启动子甲基化发生率高于以往吸烟及不吸烟者.癌组织mir-34b基因启动子甲基化水平与患者性别、年龄、PS评分无关.结论 早期NSCLC患者癌组织mir-34b基因启动子甲基化水平升高,吸烟可能与mir-34b基因启动子甲基化的发生有关.mir-34b基因甲基化与早期肿瘤发生相关的机制值得进一步研究. Objective To detect the methylation status of mir-34b gene promoter, and analyze the different methylation levels in tumor tissues and adjacent tissues in early stage non-small cell lung cancer (NSCLC) patients. Methods After bisulfite treatment of genome DNA, touchdown-nest PCR was performed to amplify the promoter CpG islands of mir-34b gene in paired tumor and adjacent tissues from 27 surgically resected stage I NSCLC patients, and the methylation status of mir-34b gene promoter was detected by clo- ning-based sequencing method. Then the correlation between methylation level and clinical factors of patients was analyzed. Results The methylation level of mir-34b gene promoter in tumor tissues was 9. 7% (6. 8-22. 3% ), while it's 8. 5% (5.3-11. 0% )in adjacent tissues. The differences between tumor and adjacent tissues were statistically significant ( Z = 2. 355, P = 0. 019). The methylation level in tumor tissues was correlated with smoking status. Conclusion Methylation level of mir-34b gene in NSCLC tissues was higher than its in adjacent tissues, which was also correlated with smoking status, suggesting a potential relationship between the tumorigenesis in early stage and the methylaiton of mir-34b gene promoter.
出处 《临床肿瘤学杂志》 CAS 2010年第11期961-965,共5页 Chinese Clinical Oncology
基金 2010年度广东省医学科学研究基金(A2010011)
关键词 Mir-34b DNA甲基化 肺癌 Mir-34b DNA methylation Non-small cell lung cancer
  • 相关文献

参考文献18

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249. 被引量:1
  • 2Coate LE,John T,Tsao MS,et al.Molecular predictive and prognostic markers in non-small cell lung cancer[J].Lancet Oncol,2009,10(10):1001-1010. 被引量:1
  • 3Iacobuzio-Donahue CA.Epigenetic changes in cancer[J].Annu Rev Pathol,2009,4:229-249. 被引量:1
  • 4Schneider PM,Praeuer HW,Stoeltzing O,et al.Multiple molecular marker testing (p53,C-Ki-ras,c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer[J].Br J Cancer,2000,83(4):473-479. 被引量:1
  • 5Custodio AB,Gonzalez-Larriba JL,Bobokova J,et al.Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer[J].J Thorac Oncol,2009,4(7):891-910. 被引量:1
  • 6Brundage MD,Davies D,Mackillop WJ.Prognostic factors in non-small cell lung cancer:a decade of progress[J].Chest,2002,122(3):1037-1057. 被引量:1
  • 7Strathdee G.Epigenetic versus genetic alterations in the inactivation of E-cadherin[J].Semin Cancer Biol,2002,12(5):373-379. 被引量:1
  • 8Schubeler D.Epigenomics:Methylation matters[J].Nature,2009,462(7271):296-297. 被引量:1
  • 9Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006,9(3):189-198. 被引量:1
  • 10Toyota M,Suzuki H,Sasaki Y,et al.Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer[J].Cancer Res,2008,68(11):4123-4132. 被引量:1

同被引文献49

  • 1高佳莉,罗玉萍,李思光.miR-34基因家族的分子进化[J].Zoological Research,2007,28(3):271-278. 被引量:13
  • 2Bartel DE MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-97. 被引量:1
  • 3Wong KY, Yu L, Chim CS. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family [J]. Epigenomics, 2011, 3(1): 83-92. 被引量:1
  • 4Fujitake S, Hibi K, Okochi O, et al. Aberrant Methylation of SOCS-1 was observed in younger colorectal cancer patients[J].J Gastroenterol,2004, 39(2): 120-4. 被引量:1
  • 5Fabbri M, Calore F, Paone A, et al. Epigenetie Regulation of miRNAs in Cancer [J]. Adv Exp Med Biol, 2013, 754:137-48. 被引量:1
  • 6He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network [J]. Nature, 2007, 447(7148): 1130-4. 被引量:1
  • 7Mazar J, Khaitan D, Deblasio D, et al. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma [J]. PIoS one, 2011, 6(9): e24922. 被引量:1
  • 8Tanaka N, Toyooka S, Soh J, et al. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer [J]. Lung Cancer, 2012,76(1):32-8. 被引量:1
  • 9Gallardo E, Navarro A, Vifiolas N, et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer [J]. Carcinogenesis, 2009, 30(11): 1903-9. 被引量:1
  • 10Wang Z, Chen Z, Gao Y, et al. DNA hyperMethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer [J]. Cancer Biol Ther, 2011, 11(5): 490-6. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部